Esperion Therapeutics soars amid vague takeover speculation
Source: SeekingAlpha
2025-07-24 13:47:09 ET
More on Esperion Therapeutics
- Can The Promise Of Profitability And Pipelines Sustain A Recovery For Esperion Therapeutics?
- Esperion Therapeutics, Inc. 2025 Q1 - Results - Earnings Call Presentation
- Esperion Therapeutics, Inc. (ESPR) Q1 2025 Earnings Call Transcript
- Esperion settles litigation with Accord Healthcare
- Esperion and HLS partner to commercialize heart disease treatments in Canada
Read the full article on Seeking Alpha
For further details see:
Esperion Therapeutics soars amid vague takeover speculation
Otsuka Holdings Co. Ltd.
NASDAQ: OTSKF
OTSKF Trading
0.0% G/L:
$67.105 Last:
107 Volume:
$67.105 Open:
OTSKF Latest News
May 17, 2025 01:00:00 am
Innovations in High Blood Pressure Intervention Benefit Patients with Resistant Hypertension
February 06, 2025 02:00:00 pm
TANAKA to Provide Medals for the Tokyo Marathon 2025 That Represent All the Participants in the Event with Woven Lines
